Location History:
- St-Catherine, CA (2005)
- Saint-Jean-sur-Richelieu, CA (2013)
- St. Jean sur Richelieu, CA (2014)
- Ste-Catherine, CA (2010 - 2022)
Company Filing History:
6 out of 3,684 
1 out of 8 Years Active: 2005-2022
Title: Kathia Levesque: Innovator in Antiviral Agents
Introduction
Kathia Levesque is a prominent inventor based in Ste-Catherine, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. With a total of seven patents to her name, her work has had a substantial impact on the treatment of viral infections.
Latest Patents
One of Kathia Levesque's latest patents focuses on "Salts of prodrugs of piperazine and substituted piperidine antiviral agents." This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. Additionally, it includes intermediate Compounds II that are useful in making prodrug Compounds I. This innovative approach aims to enhance the efficacy of antiviral treatments.
Career Highlights
Throughout her career, Kathia has worked with notable companies such as Bristol-Myers Squibb Company and ViiV Healthcare UK (No. 4) Limited. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical research and development.
Collaborations
Kathia has collaborated with esteemed colleagues, including Yasutsugu Ueda and Timothy P. Connolly. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Kathia Levesque is a trailblazer in the field of antiviral research, with a focus on innovative prodrug compounds. Her contributions continue to shape the landscape of pharmaceutical treatments for viral infections.